Company / Current Liabilities
Tyra Biosciences, Inc. Current Liabilities History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$14.6M
FY2024
5-year range
$1.9M / $15.3M
FY2020-FY2024
Trend
-4.8%
vs FY2023
Sector context
#199 of 213
Health Care
What the data says
Among 213 Health Care companies, Tyra Biosciences, Inc. is in the top 7% for current liabilities. Increased from $6M to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2024 with a 3-year CAGR of +59.2%.
Increased from $6M to $15M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +59.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 213This company $14.6M Sector average $1.6B
▼
-99.1% below sector average
Key checks
Key Insights
- 3-year CAGR of +59.2%, indicating consistent growth.
- In FY2024, current liabilities decreased 4.8% year-over-year.
- Ranks #199 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $14.6M | -4.8% |
| FY2023 | $15.3M | +169.0% |
| FY2022 | $5.7M | +57.7% |
| FY2021 | $3.6M | +94.6% |
| FY2020 | $1.9M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026